Details for New Drug Application (NDA): 065473
✉ Email this page to a colleague
The generic ingredient in CEFDINIR is cefdinir. There are twelve drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the cefdinir profile page.
Summary for 065473
Tradename: | CEFDINIR |
Applicant: | Aurobindo Pharma |
Ingredient: | cefdinir |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 065473
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CEFDINIR | cefdinir | FOR SUSPENSION;ORAL | 065473 | ANDA | A-S Medication Solutions | 50090-2735 | 50090-2735-0 | 1 BOTTLE in 1 CARTON (50090-2735-0) / 60 mL in 1 BOTTLE |
CEFDINIR | cefdinir | FOR SUSPENSION;ORAL | 065473 | ANDA | A-S Medication Solutions | 50090-6417 | 50090-6417-0 | 1 BOTTLE in 1 CARTON (50090-6417-0) / 60 mL in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SUSPENSION;ORAL | Strength | 125MG/5ML | ||||
Approval Date: | Dec 14, 2007 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SUSPENSION;ORAL | Strength | 250MG/5ML | ||||
Approval Date: | Dec 14, 2007 | TE: | AB | RLD: | No |
Complete Access Available with Subscription